Cytokinetics, Incorporated · NASDAQ:CYTK

Henderson John T received 325 Cytokinetics, Incorporated shares as an award (Form 4)

Traded Apr 15, 2026 · Filed Apr 15, 2026

On Apr 15, 2026, Henderson John T (Director) received 325 Cytokinetics, Incorporated shares as an award at US$65.37 for US$21,245, leaving 75,237 shares. Filed Apr 15, 2026 (Form 4).

Awarded
325 shares
Price
US$65.37
Value
US$21,245
Holding after
75,237 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 15, 2026Common StockAward325US$65.3775,237Direct

Source

View original at SEC

Related